Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exercise-induced changes in hemostasis markers in marathon runners: effects of enzyme supplementation and determinants.

Frontiers in physiology·2026
Same author

Exercise in regional breast cancer with neoadjuvant anthracycline-based chemotherapy with immune checkpoint-inhibition: study protocol for a prospective randomised controlled trial.

Frontiers in oncology·2026
Same author

Circulating nitric oxide pathway metabolites in heart failure with preserved ejection fraction: a sex-stratified cross-sectional analysis.

Biology of sex differences·2026
Same author

Impact of multicomponent exercise training in older individuals with and without heart failure with reduced ejection fraction - the role of functional capacity and novel biomarkers.

European journal of heart failure·2026
Same author

Assessment of nephrotoxicity following lutetium-177 PSMA I&T radioligand therapy: a comparative study with docetaxel chemotherapy.

European journal of nuclear medicine and molecular imaging·2026
Same author

Demographic and clinical profiles of drug-induced psychosis: age, gender, and social context in a German cohort.

European archives of psychiatry and clinical neuroscience·2026
Same journal

Shared frailty sieve estimation for dependent left truncated and interval censored data.

Lifetime data analysis·2026
Same journal

Functional win-fractions regression models for composite outcomes.

Lifetime data analysis·2026
Same journal

Variable selection in causal semiparametric transformation models with all-or-nothing treatment compliance.

Lifetime data analysis·2026
Same journal

Correction to: A uniformisation-driven algorithm for inference-related estimation of a phase-type ageing model.

Lifetime data analysis·2026
Same journal

Unobserved heterogeneity in threshold regression based on the hitting times of a reflected Brownian motion for recurrent hypoglycemia.

Lifetime data analysis·2026
Same journal

Variable selection with broken adaptive ridge regression for interval-censored competing risks data.

Lifetime data analysis·2026
See all related articles

Related Experiment Video

Updated: May 18, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Applying competing risks regression models: an overview.

Bernhard Haller1, Georg Schmidt, Kurt Ulm

  • 1Institut für Medizinische Statistik und Epidemiologie der Technischen Universität München, Ismaninger Straße 22, 81675 Munich, Germany. bernhard.haller@tum.de

Lifetime Data Analysis
|September 27, 2012
PubMed
Summary
This summary is machine-generated.

This study compares methods for analyzing time-to-event data with competing risks, crucial for clinical research. It highlights various regression approaches for accurate risk stratification and outcome prediction.

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Related Experiment Videos

Last Updated: May 18, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Area of Science:

  • Clinical research methodology
  • Biostatistics
  • Epidemiology

Background:

  • Clinical research often involves analyzing time-to-event data where competing events can obscure outcomes of interest.
  • Understanding risk factors and intervention effects requires specialized analytical methods when multiple event types are present.

Purpose of the Study:

  • To review and compare various analytical approaches for time-to-event data in the presence of competing risks.
  • To provide guidance for data analysts on selecting appropriate methods based on research questions, assumptions, and interpretation.
  • To apply these methods to a real-world dataset for risk stratification of cardiac death post-myocardial infarction.

Main Methods:

  • Description and comparison of cause-specific hazard regression, subdistribution hazard regression, mixture models, vertical modeling, and pseudo-observation analysis.
  • Application of these methods to a cohort study dataset.
  • Discussion of the statistical software R for implementation.

Main Results:

  • The study details multiple regression approaches for competing risks analysis.
  • It demonstrates their application in a myocardial infarction cohort for cardiac death risk stratification.
  • The comparison focuses on assumptions, methodology, and interpretation of results.

Conclusions:

  • Appropriate selection of competing risks analysis methods is vital for accurate clinical research findings.
  • The article encourages data analysts to critically evaluate different regression approaches for their specific research needs.
  • Implementation guidance using R and mention of advanced statistical literature extensions are provided.